GAUSH MEDITECH(02407): "Frequency Domain Bio-Measurement Device" awarded Chinese Medical Device Registration Certificate.

GAUSH MEDITECH (02407) announced that its subsidiary, Gaoshi Innovation Technology Co., Ltd. (Gaoshi Innovation), recently obtained the medical device registration certificate approved by the Jiangsu Provincial Drug Administration for the "Frequency-domain Biometric Instrument". The "China Eye Health White Paper" released by the National Health Commission in 2023 pointed out that the overall myopia rate of Chinese adolescents is about 53.6%. With the continuous expansion of the myopia population, the market demand for myopia prevention and control is also rapidly increasing. According to the "China Eyeglass Lens Industry Research White Paper" released by Sullivan, the market size of myopia prevention and control in China has been continuously growing in recent years, with acceleration starting after 2022. By 2023, the market size has reached RMB 14.68 billion, with a year-on-year growth of 43.2%. The biometric instrument is a key equipment for myopia prevention and control, which can accurately measure parameters such as axial length, corneal curvature, and lens thickness at the micron level. It plays an important role in monitoring the progression of adolescent myopia, evaluating the effectiveness of myopia prevention and control methods, and is also an essential equipment for precise preoperative assessment of myopia refractive surgery. The frequency-domain biometric instrument approved this time (registration certificate number: Su Xie Zhu Jun 20252161508) developed based on the new generation frequency-domain measurement principle. Compared to most traditional biometric instruments based on time-domain principles, the frequency-domain measurement principle has higher resolution, faster imaging speed, and better signal-to-noise ratio. The equipment also adopts an innovative dual optical path design (patent number: CN118526152A), which can instantly image the patient's cornea, retina, and choroid layer during eye parameter measurement, assisting doctors in screening for myopia complications during myopia follow-up visits. The equipment was independently developed by Gaoshi Innovation, taking two years, and has now achieved 100% localization of key optical, mechanical, and electrical components.